In hematological malignancies, MYO18A has been found as fusions with FGFR1, PDGFRB, and MLL in other hematopoietic malignancies (Walz et al. 2005; Ussowicz et al. 2012; Sheng et al. 2017). This evidence concerns the gene KMT2A and hematologic disorder.